Background: Ksr (kinase supressor of Ras) was identified as a regulator of the Ras-MAP kinase (mitogen-activated protein kinase) pathway by genetic screens in Drosophila and Caenorhabditis elegans. Ksr is a kinase with similarities to the three conserved regions of Raf kinases, especially within the kinase domain. To investigate whether these structural similarities correlated with common functional properties, we examined the ability of mKsr-1, the murine homolog of Ksr, to interact with components of the vertebrate MAP kinase pathway.
Murine Ksr interacts with MEK and inhibits Ras-induced transformation Background
Mitogen-activated protein kinase (MAP kinase) cascades are signaling pathways involved in several physiological processes, and have been conserved from yeast to vertebrates [1, 2] . In metazoans, the Ras oncoprotein mediates a MAP kinase cascade following its activation by extracellular mitogenic or differentiating signals. In this cascade, proteins of the Raf family function as MAP kinase kinase kinases (MAPKKK). Raf proteins have been shown to phosphorylate and activate MAPKKs (MAP kinase kinases) called MEKs (MAP kinase or ERK kinases), which in turn phosphorylate and activate MAP kinases, which are also called ERKs (extracellular signalregulated kinases). In Caenorhabditis elegans, this cascade controls vulval induction and other developmental events, and involves the let-60 (Ras family), lin-45 (Raf), mek-2 (MEK) and sur-1 (MAP kinase) genes [3, 4] . In Drosophila, this cascade, involving the Ras1, Draf, Dsor1 (MEK) and rolled (MAP kinase) genes, controls the determination of cell fate at embryonic termini, and controls neuronal differentiation of R7 photoreceptor cells (the Sevenless pathway) in the compound eye [5] [6] [7] . In vertebrates, the Raf-MEK-ERK cascade displays a higher degree of complexity: two ERKs, ERK-1 and ERK-2 [8] , two MEKs, MEK-1 and MEK-2 [9] [10] [11] [12] and three Raf proteins, A-Raf, B-Raf and c-Raf-1 [13] [14] [15] have been characterized so far. In addition to this diversity, other components also contribute to the regulation of the cascade, including dephosphorylation [16] [17] [18] and feedback controls [19] .
A novel protein kinase, Ksr (kinase supressor of Ras), identified by genetic screens in both C. elegans and Drosophila, has also been shown to regulate the MAP kinase pathway [20] [21] [22] . Specifically, loss-of-function ksr alleles block the effects of ras gain-of-function mutations in both the Drosophila Sevenless and C. elegans vulval induction pathways, but they have no effect on these pathways in otherwise wild-type animals. In addition, the ksr loss-of-function mutations are recessively lethal in Drosophila, whereas they have a lethal effect only in a small percentage of larvae in C. elegans.
Ksr appears to be evolutionarily conserved: mammalian homologs, mKsr-1 and hKsr-1, have been isolated from mice and humans, respectively [20] . In agreement with the genetic observations in Drosophila and C. elegans, mKsr-1 was found to cooperate with activated Ras to promote Xenopus oocyte maturation [23, 24] . Although several recent reports showed that mKsr-1 and Raf-1 can form membrane-bound complexes, the experiments did not support the possibility of a direct interaction between the two proteins, but rather suggested the requirement for an intermediate molecule [23] [24] [25] . Furthermore, experiments assessing the ability of mKsr-1 to phosphorylate and/or activate Raf-1 had contradictory results.
Interestingly, the Raf family kinases are the closest relatives to Ksr; the sequence of the kinase domain of mKsr-1 is 35.1% and 33.7% identical to those of B-Raf and Raf-1, respectively. In addition, mKsr-1 shares other structural similarities with Raf kinases, including a cysteine-rich motif (CA3 domain) which is present in the CR1 domain of Raf, and a serine/threonine-rich sequence (CA4) that resembles the CR2 of Raf [20] . Because of these structural similarities, and in the absence of a precise mechanistic understanding of how Ksr regulates the MAP kinase pathway, the possibility that Ksr may act in parallel to Raf kinases cannot be ruled out.
To further address this issue, we have investigated the relationship between mKsr-1 and different components of the Ras-MAPK pathway in vertebrates. We show that mKsr-1, like Raf-1 and B-Raf, interacts directly with MEK. No MEK phosphorylation is seen as a result, and MEK autophosphorylation activity is blocked. Accordingly, mKsr-1 reduced NIH3T3 cell transformation induced by Ras. In addition, overexpression of mKsr-1 significantly inhibited Ras-and B-Raf-induced proliferation of chicken embryonic neuroretina (NR) cells. In contrast, overexpression of mKsr-1 was not sufficient to abolish NR cell proliferation induced by a constitutively activated MEK-1 protein, consistent with a mechanism of action at the level of MEK. Taken together, our results raise the possibility that Ksr could regulate the MAP kinase pathway by a previously unidentified mechanism involving the formation of Ksr-MEK complexes.
Results

Interaction of mKsr-1 with MEK
To investigate the role of Ksr in the regulation of the vertebrate MAP kinase cascade, we tested its ability to interact with different components of this pathway. Various fragments of mKsr-1, the murine homolog of ksr [20] , were subcloned in-frame with GAL4 sequences in yeast two-hybrid vectors, and the proteins were tested for their ability to interact with constitutively activated Ras (RasV12), Raf-1, B-Raf, MEK-1 or MEK-2. Constructs encoding recombinant proteins were co-transfected into the yeast strain Hf7c containing the HIS3 and lacZ reporter genes. Transformants were tested for their ability to grow in the absence of histidine and for β-galactosidase activity. The results presented in Figure 1 show that mKsr-1 did not bind directly to Raf-1, B-Raf or Ras. In contrast, we detected significant interaction between mKsr-1 and both mammalian MEK-1 and MEK-2 ( Figure 1b) . The affinity of this interaction appeared to be weak (expressed as a His + /LacZ -phenotype, Figure 1b ) when tested with full-length mKsr-1, but steadily increased as amino-terminal sequences were deleted from the protein. Specifically, a region of mKsr-1 restricted to the kinase domain (Ksr CA5, Figure 1a ) strongly interacted with MEKs; the binding affinity was lower than that observed with B-Raf, but higher than that found with Raf-1. Thus, as observed with Raf-MEK interactions, the binding of Ksr to MEK was mediated through its kinase domain. In confirmation of this, an amino-terminal moiety of mKsr-1 lacking the CA5 domain did not bind to MEK Research Paper Interaction of mKsr-1 with MEK Denouel-Galy et al. 47
Figure 1
Murine Ksr interacts with mammalian MEK-1 and MEK-2 in the yeast two-hybrid system. (a) Schematic representation of the various portions of mKsr-1 tested in the two-hybrid system. The CA1, CA2, CA3, CA4 and CA5 conserved regions of Ksr proteins are indicated in blue boxes. CA3 contains a cysteine-rich motif (C) and CA4 contains a serine/threonine-rich motif (S/T). Amino-acid residue numbers of each construct are indicated. (b) The two-hybrid system was used to determine interactions between the constructs depicted in (a), and either hamster MEK-1, mouse MEK-2, human Raf-1, quail B-Raf or human Ha-RasV12 [32] . HIS3 expression levels (His) and the qualitative β-galactosidase activity (LacZ) are indicated. For HIS3 expression, + indicates His + colonies observed within 2 days andindicates no growth in the absence of histidine. For β-galactosidase activity, ++++ indicates a very strong interaction (blue color development within 1 h), ++ a strong interaction (blue color development within 2 h), + an intermediate interaction (blue color development after 6 h), -no blue color development. Weak interactions are indicated by His + /LacZ -transformants. His -/LacZindicates an absence of interaction. All the interactions were tested in both orientations for each pair of proteins, with identical results. (data not shown). In addition, the Ksr-MEK interaction appears to be highly specific, because mKsr-1, like Raf-1 and B-Raf, did not interact with the distantly related MAP kinase kinases MKK-3 and MKK-4 [26] in the two-hybrid system (data not shown).
To confirm the Ksr-MEK interaction using another experimental approach, we raised specific antibodies against the carboxyl terminus of mKsr-1 and performed co-immunoprecipitation experiments. COS-1 cells were transfected with a plasmid encoding full-length mKsr-1 (pSVL/mKsr-1) and cell lysates were immunoprecipitated with either anti-mKsr-1 or anti-MEK-1 specific antisera.
Immunoprecipitates were resolved by SDS-PAGE and western blotting was used to visualize mKsr-1 and MEK-1. Ectopically expressed mKsr-1 migrated as a doublet of 108-115 kDa, which was not detectable in cells transfected with the control vector or in untransfected cells (Figure 2 ). Western blotting with anti-MEK-1 revealed the presence of MEK in the mKsr-1 immunoprecipitates (Figure 2a ). This co-immunoprecipitation was also observed in COS-1 cells expressing MEK-1 protein tagged with hemagglutinin (HA1), using an anti-HA1 monoclonal antibody for western blotting (Figure 2b ). Furthermore, we found that mKsr-1 could be co-immunoprecipitated with endogenous MEK-1, using an anti-MEK-1 antiserum (Figure 2a ). We also found that full-length mKsr-1 associated with MEK-1 in vitro. As shown in Figure 2c , mKsr-1 translated in rabbit reticulocyte lysate interacted with immobilized GST-MEK-1 fusion protein but not with GST protein alone, confirming that the Ksr-MEK interaction is direct. We also investigated the existence of Ksr-MEK complexes in a cell system in which neither protein was overexpressed. We found that Ksr was expressed at detectable levels in PC12 cells and that endogenous MEK could be detected in 
The MEK fraction complexed with Ksr is inactive
Because Ksr and Raf proteins have structural similarities and share the ability to interact directly with MEK, we considered the possibility that mKsr-1 could regulate the MAP kinase pathway by directly activating MEK. We repeatedly failed to detect phosphorylation of MEK by Ksr using different sources of MEK as substrates, however, including immunoprecipitated or GST-fusion proteins (data not shown). On the contrary, the binding of MEK and Ksr appeared to inhibit the autophosphorylation activity of MEK. Thus, we could not detect phosphorylation of the MEK subpopulation complexed with endogenous Ksr in PC12 cells, even after treating the cells with epidermal growth factor (EGF) or nerve growth factor (NGF; Figure 3b ). However, given that relatively little MEK precipitated with Ksr antibodies, it is difficult to draw conclusions about MEK activity from these experiments. We therefore investigated MEK activity in COS-1 cells overexpressing mKsr-1 at levels sufficiently elevated to allow detection of significant amounts of MEK immunoprecipitated with Ksr antibodies. Results presented in Figure 4 indicate that the MEK subpopulation complexed with mKsr-1 in COS-1 cells could not be detected in an in vitro kinase assay ( Figure 4 , lane 2), suggesting that MEK is not phosphorylated by Ksr and does not display kinase activity. In contrast, MEK-1 immunoprecipitated directly or from the supernatant of mKsr-1 immunoprecipitation underwent autophosphorylation ( Figure 4, lanes 1,3) .
Specific inhibition by mKsr-1 of Ras-induced NIH3T3 cell transformation
Because the interaction of MEK with mKsr-1 appeared to block MEK in an inactive state, we investigated the consequence of mKsr-1 expression on fibroblast transformation induced by Ras, which normally requires MEK activity. Transformation by activated Ras has been shown to involve distinct signaling pathways [27, 28] mediated by at least four different effectors: Raf-1 [29, 30] , B-Raf [31, 32] , Ral guanine nucleotide dissociation stimulator (Ral-GDS) [33] [34] [35] [36] and the catalytic subunit of phosphatidylinositol-3-OH kinase (PI 3-kinase) [37, 38] have all been reported to interact directly with Ras in vertebrates. In addition, indirect activation of Rac and Rho has been shown to contribute to the morphological transformation of cells induced by Ras [39] [40] [41] . We examined the effect of mKsr-1 expression on NIH3T3 cell transformation induced by activated versions of Ras, Rac, Rho and Ral. Plasmids encoding each protein were transfected into NIH3T3 cells, either alone or in combination with mKsr-1, and focus formation assays were caried out over 2 weeks. Immunoprecipitates were subjected to an in vitro kinase assay (b) and the corresponding immunoprecipitates assayed for the levels of MEK-1/2 and Ksr-1 by western blotting (c).
Expression of full-length mKsr-1 alone did not lead to cell transformation ( Figure 5 ). Interestingly, the number of transformed foci was reproducibly reduced by about 60% in fibroblasts co-transfected with both RasV12 and mKsr-1, compared to control cells. In contrast, co-transfection of mKsr-1 had no significant effect on transformation induced by activated Rac (RacV12) or activated Rho (RhoV14). Finally, we did not observe a significant cooperative effect when activated Ral (RalL72), which is not transforming by itself, was co-transfected with mKsr-1.
In these experiments, we used only 5 ng of RasV12 plasmid, compared to 500 ng for the other constructs, because of the higher transformation efficiency of Ras; transfection assays using 500 ng of RasV12 plasmid followed by appropriate cell dilutions led to similar results, however (data not shown). To confirm that mKsr-1 was not able to cooperate with Ras in cell transformation, we also investigated the effect of mKsr-1 in co-transfection assays with three different RasV12 mutants that differ in their ability to bind to Ras effectors. Each mutant was previously shown to bind to only one of the three direct Ras effectors: RasS35 binds only to Raf, RasG37 to Ral-GDS and RasC40 to the p110 catalytic subunit of PI 3-kinase [28] . None of these mutants is able to transform cells when expressed alone, but RasG37 and RasC40 can synergize with Raf-1, and RasS35 and RasG37 with PI 3-kinase, to induce transformation [28] . We found that co-transfection of mKsr-1 with any of these mutants did not result in significant transformation of NIH3T3 cells ( Figure 5 ). Taken together, these results confirm that mKsr-1 does not cooperate with Ras for fibroblast transformation.
Inhibition by mKsr-1 of the proliferation of neuroretina cells induced by Raf or Ras but not that induced by MEK
Because our observation that mKsr-1 inhibited Rasinduced fibroblast transformation appeared to contradict previous studies reporting cooperative effects of Ras and Ksr in other biological systems, we investigated whether the inhibitory effect of mKsr-1 on the Ras-MAPK pathway could be observed in another cell type. We have previously reported that constitutive activation of Raf-1 and B-Raf was sufficient to induce sustained proliferation of chicken embryonic NR cells, which are normally quiescent in culture [42, 43] . We used this cell system to test the effect of mKsr-1 overexpression on cell proliferation induced by activators of the MAP kinase pathway. NR cultures were infected with either C11, IC11 or RCAS/MEK DD avian retroviruses, which express v-Ha-Ras [44] , v-Rmil (an activated version of the avian homolog of B-Raf) [43] , and a constitutively activated MEK-1 protein in which serine residues 218 and 222 are substituted by aspartic acid residues [45] , respectively. It is noteworthy that the growth rate of NR cells infected with C11 and RCAS/MEK DD viruses was higher than that of the IC11-infected cells (data not shown). Exponentially growing infected cultures were then transfected with either pRcRSV/mKsr-1 or empty pRcRSV plasmids. Focus formation by proliferating NR cells was examined after selection for neomycin-resistant cells. Overexpression of mKsr-1 markedly decreased both the number and the size of foci of proliferating NR cells in C11-and IC11-infected cultures, compared to cultures transfected with the pRcRSV empty vector ( Figure 6 ). This effect appeared more pronounced in C11-than in IC11-infected NR cells, suggesting that mKsr-1 competes more efficiently with endogenous Raf proteins in C11-infected cells than with overexpressed and constitutively activated B-Raf protein in IC11-infected cells, for the binding to MEK. In contrast, overexpression of mKsr-1 did not significantly decrease the number of foci of proliferating cells in RCAS/MEK DDinfected NR cultures, although the size of the foci appeared to be reduced. 
Discussion
Ksr was identified as a positive regulator of the Ras-MAP kinase pathway by genetic screens in Drosophila and C. elegans. Recent reports have indicated that the murine homolog of Ksr, mKsr-1, positively regulates the MAP kinase pathway in vertebrates, as it is able to cooperate with Ras during Xenopus oocyte maturation. The precise mechanism of mKsr-1 action remains unclear, however [23] [24] [25] . In this study, we investigated the possible interaction of mKsr-1 with different components of the vertebrate Ras-MAP kinase pathway. Our results demonstrate that mKsr-1 does not bind to mammalian RasV12, in agreement with previous reports that the Drosophila and C. elegans homologs of Ras did not interact with Ksr in the two-hybrid system [20, 22] . Although the CA3 domain of mKsr-1 contains a cysteine-rich motif similar to the one in Raf that is involved in increasing the affinity of the Raf-Ras interaction [46] , mKsr-1 lacks the minimal Rasbinding domain of Raf proteins that is located upstream of the cysteine-rich motif in the CR1 domain [47] .
We also found that mKsr-1 did not bind directly to Raf-1 or to B-Raf in the two-hybrid system. This observation strengthens the possibility that the interaction observed between Raf-1 and mKsr-1 in co-immunoprecipitation experiments is indirect and might be mediated by another molecule [23, 24] . A candidate for this mediator could be a protein of the 14-3-3 family, because Ksr contains 14-3-3-binding motifs similar to those of Raf proteins. It was recently reported that 14-3-3ζ interacts with Ksr [24] . However, a Raf-phosphopeptide containing the 14-3-3-binding motif was shown to inhibit 14-3-3 binding to Ksr, but not the Raf-1-Ksr interaction, suggesting that the association of Raf-1 and Ksr is not mediated by 14-3-3 [24] .
The data presented here suggest that another candidate for mediating the Ksr-Raf interaction could be MEK. Indeed, we have shown, using three different experimental approaches, that MEK and Ksr can form complexes. MEK could be co-immunoprecipitated with both full-length mouse Ksr-1 overexpressed in COS-1 cells and endogenous Ksr-1 in rat PC12 cells, suggesting that this interaction takes place in vivo. We also found that full-length mKsr-1 associated with MEK-1 in vitro, thus confirming that the Ksr-MEK interaction is direct. This interaction appears to be strong: it is detected in the yeast two-hybrid system with an affinity comparable to B-Raf-MEK and Raf-1-MEK interactions. In this system, however, the full-length Ksr protein displayed a much lower affinity for MEK than that observed with the isolated kinase domain (growth in the absence of histidine could be seen but there was no detectable β-galactosidase activity for the full-length protein). This may be because of incorrect folding of the full-length protein, or because of a defect in its nuclear transport; the recombinant protein is likely to exceed 120 kDa in size when fused to Gal4. The observation that Ksr binds MEK is compatible with the structural similarity that Ksr shares with Raf: Raf and Ksr proteins are more closely related to each other than they are to other kinases such as MEKK1 and Mos, both of which are also able to phosphorylate and activate MEK-1, at least in vitro [48, 49] .
These observations suggested that Ksr could act as a MEK kinase, but we and others failed to detect direct phosphorylation and activation of MEK by Ksr. On the contrary, we observed that the kinase activity of MEK was inhibited when MEK was bound to Ksr. We recently observed that overexpression of mKsr-1 was not sufficient to induce proliferation in primary cultures of avian post-mitotic NR cells, although overexpression of Raf-1 and B-Raf was sufficient (C.P., A.D-G., D.L., G.C. and A.E., unpublished observations). Similarly, transfected mKsr-1 did not induce phenotypic changes in NIH3T3 cells ( Figure 5 ), and furthermore, mKsr-1 significantly decreased Ras-induced transformation in NIH3T3 cells, a result consistent with the ability of mKsr-1 to block MEK in an inactive state. This effect is likely to be mediated through regulation of the MAP kinase pathway, given that mKsr-1 expression did not reduce the transformation induced by other activated GTPases such as Rac or Rho. In addition, the inability of mKsr-1 to cooperate with Ras in transformation was confirmed by the fact that mKsr-1 did not synergize with Ras effector mutants to induce transformation. The inhibitory effect of mKsr-1 on the MAP kinase pathway in vivo is not restricted to established fibroblasts; we found that overexpression of mKsr-1 significantly inhibited Ras-and B-Raf-induced chicken embryonic NR cell proliferation. In contrast, overexpression of mKsr-1 was not sufficient to abolish NR cell proliferation induced by a constitutively activated MEK-1 protein (MEK DD ), in agreement with a mechanism of action at the level of MEK. We observed a slight decrease in the growth rate of these cells, however, perhaps because MEK DD retains the capacity to interact with Ksr (data not shown).
Thus, Ksr appears to act as an inhibitor rather than an activator of MEK in the biological assays used in this study. A simplistic model would be that Ksr is a regulated attenuator of the Ras-MAP kinase cascade in vivo, inhibiting the pathway at the level of MEK (Figure 7a) . However, this model contradicts the results of previous studies suggesting that Ksr positively regulates the Ras-MAP kinase pathway. Alternative possible models could be proposed to explain this apparent discrepancy: for example, Ksr may be a MEK kinase, or may be a co-activator of MEK (Figure 7b,c) . We do not exclude the possibility that Ksr could be a MEK kinase, although we failed to demonstrate that mKsr-1 can activate MEK. Perhaps mKsr-1 is in an inactive conformation in the cell systems used in this study, thus preventing the phosphorylation, activation and release of MEK. An objection to a model in which Ksr is a MEK kinase is that if Ksr and Raf proteins compete for the same substrate, they would not be expected to colocalize, and it would remain to be determined why these proteins are found in the same membrane-bound complex [23, 24] . Alternatively, mKsr-1 could be a MAP kinase kinase kinase with a different substrate specificity from Raf kinases. Because Ksr shares structural similarities with Raf, Ksr, when overexpressed, could bind MEK in a nonphysiological manner, without phosphorylating it. This possibility is unlikely, however, because endogenous Ksr and MEK co-immunoprecipitated in PC12 cells, a strong affinity was detected in the two-hybrid system, and because there was no interaction between mKsr-1 and other known MAP kinase kinases (MKK-3 and MKK-4). Another possibility is that mKsr-1 is not a MEK kinase by itself but rather serves as a co-activator by stabilizing the Raf-MEK complex, or by presenting MEK to Raf for phosphorylation and activation (Figure 7c ). Although this model does not explain why Raf and Ksr are structurally similar, or the role of the putative kinase activity of Ksr, it could nevertheless explain the interaction of Ksr with Raf and why Ksr does not phosphorylate MEK. In this hypothesis, an explanation for the ability of Ksr to inhibit 52 Current Biology, Vol 8 No 1
Figure 7
Alternative models for Ksr function. Ras signaling that was observed in both NIH3T3 and NR cells could be either that the cells lack a signal required to activate Ksr or that the overexpression of Ksr could titrate MEK and sequester it out of the Ras-Raf complex, thereby preventing its activation.
Some of these models imply that Ksr must be activated before it can regulate MEK activation, and that the pathway activating Ksr was not stimulated in the conditions used in this study. Interestingly, several lines of evidence suggest that Ksr and Raf proteins are differentially regulated. First, it appears clear from our results that mKsr-1 is not regulated by Ras, as Raf is. Second, the kinase domain of Raf proteins can be constitutively activated by truncation of the amino terminus of the proteins, whereas similar deletions in Ksr produced constitutive dominant-negative effects on the Ras-MAP kinase cascade in both the Drosophila Sevenless and Xenopus oocyte maturation pathways [23] . That the amino terminus of mKsr-1 is required for its activity is also suggested by the identification of a loss-of-function mutation located in the CA1 domain of Drosophila Ksr [20] . We have not yet identified any stimulus that can activate Ksr. Zhang et al. [25] have reported that Ksr is activated by ceramide in vitro, however, and by factors, such as TNFα, which increase ceramide levels in cells. In addition, they found that Ksr complexes with, phosphorylates and activates Raf-1 in vitro and in vivo. We have not detected activation of Ksr by ceramide or activation of Raf-1 by Ksr. The reasons for this discrepancy are at present unclear. It is noteworthy that Ksr loss-of-function mutations have no effect by themselves on Drosophila Sevenless and C. elegans vulval induction pathways in otherwise wild-type animals, suggesting that Ksr is dispensable for these terminal differentiation pathways. In contrast, these mutations induce embryonic lethality in the same hosts suggesting an important role for Ksr in early development. Interestingly, the biological system in which mammalian Ksr-1 was shown to cooperate with activated Ras is the maturation of the Xenopus oocyte. It is therefore conceivable that the components of the signaling pathway activating Ksr are absent or repressed in the differentiated cell types used in this study.
Conclusions
We provide evidence that, like Raf proteins, the kinase supressor of Ras (Ksr) interacts directly with the MAP kinase kinase MEK. Overexpression of mKsr-1 inhibits both Ras-induced transformation of established fibroblasts and the proliferation of chicken embryonic neuroretina cells induced by Ras or B-Raf. Overexpression of mKsr-1 is not sufficient to abolish cell proliferation induced by a constitutively activated MEK-1 protein, however. Taken together, our results suggest a role for Ksr in regulating the MAP kinase pathway at least in part through its ability to form a complex with MEK, and the results raise the possibility of a previously unidentified function for Ksr.
Materials and methods
Cell cultures
COS-1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% newborn calf serum [50] . Transfections of these cells were carried out using the DEAE-Dextran method [50] . For serum stimulation, COS-1 cells were starved overnight in DMEM containing 0.4% BSA and treated with 20% newborn calf serum for 10 min. PC12 cells were cultured in DMEM containing 10% horse serum and 5% fetal calf serum. For growth factor stimulation, cultures at 80% confluency were serum starved overnight in 0.4% serum and stimulated with EGF (Calbiochem) at 50 ng/ml for 2 min, or NGF (Boehringer Mannheim) at 50 ng/ml for 5 min. NIH3T3 cells were cultured in DMEM containing 10% newborn calf serum. Neuroretina (NR) cell cultures were prepared from 8 day-old Brown Leghorn chicken embryos [51] . Cultures were maintained and passaged in Eagle basal medium supplemented with 8% fetal calf serum. Viral stocks of avian retroviruses were used to infect NR cultures: IC11 virus contains the v-Rmil oncogene, an activated version of the avian homolog of B-Raf [43] , and C11 virus (kindly provided by Thomas Graf) contains the v-Ha-Ras oncogene [44] .
Plasmid constructions and anti-mKsr-1 serum preparation
Different portions of the murine Ksr-1 cDNA (kindly provided by Gerald Rubin) were inserted into two-hybrid vectors in-frame with either sequences encoding the Gal4 DNA-binding domain (pGBT9), or sequences encoding the Gal4 transcriptional activation domain (pGADGH). Fusions with full-length mKsr-1 were obtained by subcloning the 4 kb EcoRI Ksr fragment from pMA57. The Ksr∆CA1 construct contains the XhoI fragment encoding the mKsr-1 amino-acid sequence from Arg187 to the stop codon. The KsrCA5 construct contains the ApaI fragment encoding the mKsr-1 amino-acid sequence from Gly540 to the stop codon. The reading frames of each fusion construct between GAL4 and Ksr sequences was verified by sequencing. The other constructs encoding fusion proteins with either Raf-1, B-Raf, Ha-RasV12, MEK-1 or MEK-2 have been described previously [32] .
The pSVL/mKsr-1 expression vector was obtained by subcloning the SpeI-XbaI fragment (including the mKsr-1 EcoRI fragment) from pGAD-GH/mKsr-1 into the XbaI cloning site of pSVL (Pharmacia). The pRcRSV/mKsr-1 expression vector was generated by subcloning the SpeI-XbaI fragment from pGAD-GH/mKsr-1 into the SpeI and XbaI cloning sites of pRcRSV vector (Invitrogen), which contains the neomycin-resistance gene. Constructs expressing activated versions of Ras (pSG5/RasV12), Rac (pEXV3/RacV12), Rho (pEXV3/RhoV14), Ral (pMT2/RalL72), as well as Ras effector mutants in a V12 background (Ser35, Gly37 and Cys40), have been described elsewhere [28] . The pECE/HA-MEK-1 plasmid encoding the hemagglutinin (HA1) epitope-tagged MEK-1 protein was kindly provided by Jacques Pouysségur [52] . The RCAS/MEK DD virus was obtained as follows: the cDNA encoding MEK DD [45] was cloned into the HindIII and SacI cloning sites of the CLA12 adaptor plasmid [53] in order to flank the cDNA by ClaI sites. The resulting ClaI fragment was then cloned into the unique ClaI site of the RCAS-A retroviral vector [53] . A rabbit polyclonal antibody was raised against a peptide corresponding to the carboxy-terminal sequence of mKsr-1: RFERFGLGTLESGNPKM (in single-letter amino-acid code). This antibody was then affinity purified over a peptide column.
Yeast two-hybrid system
Yeast cultures were grown as described previously [32] . The Saccharomyces cerevisiae strain Hf7c [54] was co-transformed with the different pGBT9-and pGADGH-derived constructs by the lithium acetate method [55] . Co-transformants were plated on solid SC medium lacking tryptophan, leucine and histidine to select for growth in the absence of histidine. Qualitative determination of β-galactosidase activity was performed on colonies patched on SC-Trp -Leu -plates by a filter assay using 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) as substrate, essentially as previously described [56] . The strength of the interaction between both proteins was tested in the two opposite orientations and assessed by both HIS3 and lacZ expression [32] .
In vitro binding experiments
The 4 kb EcoRI Ksr fragment encoding the full-length mKsr-1 was subcloned into the Bluescript pBKS(-) vector (Stratagene) and in vitro T7-driven transcription and translation was performed in micrococcal reticulocyte lysates using the TNT-coupled transcription/translation kit (Promega) with [ 35 S]methionine as the radioactive tracer amino acid in a final volume of 50 µl. For binding experiments, 20 µl of the reaction was incubated overnight at 4°C with 10 µg of immobilized GST alone or GST-MEK-1 fusion protein (Upstate Biotechnology) in the presence of 0.1 mM AEBSF (Interchim). After centrifugation, the supernatant containing the unbound fraction was removed and the beads were washed five times with buffer containing 0.2% Triton X-100, 10 mM Tris pH 8.0, 150 mM NaCl and 2 mM EDTA. The bound proteins were then eluted by boiling in gel sample buffer, resolved by SDS-PAGE and transferred to Immobilon-P membranes (Millipore). Membranes were autoradiographed before western blotting.
Immunoprecipitations from COS-1 cells
COS-1 cells were transfected, and lysed 48 h later in Triton X-100 lysis buffer [50] . Cell lysates were incubated with either the anti-mKsr-1 antibody at a 1:350 dilution, a rabbit antibody directed against an amino-terminal peptide of MEK-1 (a gift of Jacques Pouysségur [52] Immunoprecipitations from PC12 cells PC12 cells which had been stimulated with EGF (2 min) or NGF (5 min) were harvested in 1 ml of lysis buffer (containing 50 mM Hepes, 100 mM NaCl, 1 mM EGTA, 1% Triton X-100, 2 mM NaF, 2 mM Na pyrophosphate, 0.5 mM sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonylfluoride, 1 mM para-nitrophenylphosphate, and 10 mg/ml each of leupeptin, pepstatin and aprotinin) and the lysates cleared for 15 min at 15,000 rpm. For co-precipitation, the lysates were immunoprecipitated with either a MEK-1/2 polyclonal antibody (Transduction Laboratories; 1:250 dilution), the mKsr-1 polyclonal antibody (1:250 dilution) or the Ksr pre-immune serum (1:250 dilution), in the presence or absence of the immunizing Ksr peptide (10 µM). Immunoprecipitations were carried out for 60 min at 4°C followed by a 30 min incubation with protein-G-Sepharose (Sigma; 40 µl of a 1:1 slurry). Immunoprecipitates were then washed three times in PBS-0.1% Triton X-100, resolved by 10% SDS-PAGE and transferred to nitrocellulose. Immune complexes were probed for the presence of Ksr and MEK using the Ksr-1 polyclonal antibody at a 1:1000 dilution, or a mix of the monoclonal MEK-1 (1:1000) and MEK-2 (1:2500) antibodies (Transduction Laboratories). For the in vitro kinase assays, immunoprecipitates were washed three times in PBS-0.1% Triton X-100 followed by two washes in the kinase buffer (25 mM Hepes pH 8.0, 10 mM MgCl 2 , 2 mM MnCl 2 ). The kinase assay was carried out in a final volume of 25 µl with 5 µCi of [γ-32 P]ATP per reaction, for 30 min at room temperature. Reactions were stopped with Laemmli sample buffer, resolved by 10% SDS-PAGE and transferred to nitrocellulose. Membranes were autoradiographed before western blotting with anti-Ksr and anti-MEK antibodies as described above.
Transformation assays in NIH3T3 cells
Transformation assays were performed essentially as described previously [28] . Briefly, low passage NIH3T3 cells were seeded at 1.5 × 10 5 per well in six-well dishes the day before lipofection (lipofect-AMINE reagent from Gibco-BRL) with 0.5 µg of each plasmid (apart from pEXV3/RasV12 for which only 5 ng were used). Two days later, the cells were transferred to 10 cm dishes. After reaching confluence, the dishes were kept in DMEM containing 5% calf serum for two weeks, after which they were stained with 1.0% crystal violet (in 20% ethanol) to visualize foci.
NR cell transfections
NR cultures induced to proliferate upon infection with C11, IC11 and RCAS/MEK DD viruses were transfected by the calcium phosphate method [57] . One day before transfection, proliferating NR cultures were seeded at 10 6 cells per 100 mm dish. Cells were then transfected with equal amounts of either pRcRSV/mKsr-1 or empty pRcRSV plasmids (varying the amount of DNA between 1 and 10 µg gave rise to comparable results) and G418 selection was applied 7 days later for 7 days. Cells were then rinsed with PBS, and foci of proliferating NR cells were stained with 1.0% crystal violet (in 20% ethanol).
